BPDG30: Drug product development

Broadcast date

 

Presented by

 

Quick Description

The 30th meeting of the BioPhorum Development Group brought together 156 participants, from 30 companies. The meeting’s purpose was to share knowledge and discuss the challenges industry is experiencing in Drug Product (DP) formulation and process development. The format was a mix of presentations, hot topic facilitated panel discussions and a future DP opportunities concept board session.

Details

The 30th meeting of the BioPhorum Development Group brought together 156 participants, from 30 companies. The meeting’s purpose was to share knowledge and discuss the challenges industry is experiencing in Drug Product (DP) formulation and process development. The format was a mix of presentations, hot topic facilitated panel discussions and a future DP opportunities concept board session.

Topics covered in the meeting were:

  • Polysorbate challenges
  • Automation of DP robustness studies, Drying technology advances
  • High concentration formulation challenges.

The Formulation workstream showcased their forward-looking approach on the hot topic Compatibility assessment of closed system drug transfer devices (CSTDs) and Patient centric drug products: new delivery technologies was a hot topic panel discussion supported by benchmarking survey results.

Speakers